Correlation Between Morningstar Unconstrained and VTv Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Morningstar Unconstrained and VTv Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morningstar Unconstrained and VTv Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morningstar Unconstrained Allocation and vTv Therapeutics, you can compare the effects of market volatilities on Morningstar Unconstrained and VTv Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morningstar Unconstrained with a short position of VTv Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morningstar Unconstrained and VTv Therapeutics.

Diversification Opportunities for Morningstar Unconstrained and VTv Therapeutics

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Morningstar and VTv is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Morningstar Unconstrained Allo and vTv Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on vTv Therapeutics and Morningstar Unconstrained is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morningstar Unconstrained Allocation are associated (or correlated) with VTv Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of vTv Therapeutics has no effect on the direction of Morningstar Unconstrained i.e., Morningstar Unconstrained and VTv Therapeutics go up and down completely randomly.

Pair Corralation between Morningstar Unconstrained and VTv Therapeutics

Assuming the 90 days horizon Morningstar Unconstrained is expected to generate 1.46 times less return on investment than VTv Therapeutics. But when comparing it to its historical volatility, Morningstar Unconstrained Allocation is 9.8 times less risky than VTv Therapeutics. It trades about 0.07 of its potential returns per unit of risk. vTv Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  3,120  in vTv Therapeutics on August 30, 2024 and sell it today you would lose (1,569) from holding vTv Therapeutics or give up 50.29% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Morningstar Unconstrained Allo  vs.  vTv Therapeutics

 Performance 
       Timeline  
Morningstar Unconstrained 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Morningstar Unconstrained Allocation are ranked lower than 4 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Morningstar Unconstrained is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
vTv Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in vTv Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, VTv Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Morningstar Unconstrained and VTv Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Morningstar Unconstrained and VTv Therapeutics

The main advantage of trading using opposite Morningstar Unconstrained and VTv Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morningstar Unconstrained position performs unexpectedly, VTv Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VTv Therapeutics will offset losses from the drop in VTv Therapeutics' long position.
The idea behind Morningstar Unconstrained Allocation and vTv Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world